[go: up one dir, main page]

DK1291343T3 - Hydroxyformamidin-derivater og lægemidler indeholdende disse - Google Patents

Hydroxyformamidin-derivater og lægemidler indeholdende disse

Info

Publication number
DK1291343T3
DK1291343T3 DK01941061T DK01941061T DK1291343T3 DK 1291343 T3 DK1291343 T3 DK 1291343T3 DK 01941061 T DK01941061 T DK 01941061T DK 01941061 T DK01941061 T DK 01941061T DK 1291343 T3 DK1291343 T3 DK 1291343T3
Authority
DK
Denmark
Prior art keywords
group
formula
substituted
represented
participates
Prior art date
Application number
DK01941061T
Other languages
Danish (da)
English (en)
Inventor
Masakazu Sato
Noriyuki Miyata
Takaaki Ishii
Yuko Kobayashi
Hideaki Amada
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK1291343T3 publication Critical patent/DK1291343T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK01941061T 2000-06-15 2001-06-15 Hydroxyformamidin-derivater og lægemidler indeholdende disse DK1291343T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000180477 2000-06-15
JP2000180479 2000-06-15
JP2000336140 2000-11-02
JP2000359781 2000-11-27
PCT/JP2001/005108 WO2001096309A1 (fr) 2000-06-15 2001-06-15 Derives hydroxyformamidine et medicaments les contenant

Publications (1)

Publication Number Publication Date
DK1291343T3 true DK1291343T3 (da) 2007-02-05

Family

ID=27481364

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01941061T DK1291343T3 (da) 2000-06-15 2001-06-15 Hydroxyformamidin-derivater og lægemidler indeholdende disse

Country Status (12)

Country Link
US (1) US6670382B2 (fr)
EP (1) EP1291343B1 (fr)
JP (1) JP4904659B2 (fr)
KR (1) KR100776095B1 (fr)
CN (1) CN1177824C (fr)
AT (1) ATE347546T1 (fr)
AU (2) AU7453501A (fr)
CA (1) CA2411418C (fr)
DE (1) DE60125036T2 (fr)
DK (1) DK1291343T3 (fr)
ES (1) ES2280379T3 (fr)
WO (1) WO2001096309A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE347546T1 (de) 2000-06-15 2006-12-15 Taisho Pharmaceutical Co Ltd Hydroxyformamidin-derivate und diese enthaltende medikamente
CN1272313C (zh) 2001-04-26 2006-08-30 大正制药株式会社 20－羟基二十碳四烯酸生成抑制剂
GB2376609B (en) * 2001-05-02 2003-06-18 Symbian Ltd Group communication method for a wireless communication device
WO2003022821A1 (fr) * 2001-09-06 2003-03-20 Taisho Pharmaceutical Co., Ltd. Derive d'heterocycle presentant une activite inhibitrice de l'enzyme de production du 20-hete
AU2003262069A1 (en) 2002-09-12 2004-04-30 Taisho Pharmaceutical Co., Ltd. N-hydroxyformamidine derivative
PL2272490T3 (pl) * 2005-07-29 2020-05-18 Basf Se Stabilizacja produktów do pielęgnacji ciała i stosowanych w gospodarstwach domowych przed rozkładem w wyniku promieniowania uv z zastosowaniem pochodnych merocyjaniny
CN101657423B (zh) * 2007-02-22 2013-11-06 先正达参股股份有限公司 亚胺吡啶衍生物和它们作为杀微生物剂的用途
JP6311845B2 (ja) * 2016-02-15 2018-04-18 大正製薬株式会社 アゾールで置換されたピリジン化合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998970A (en) 1975-04-28 1976-12-21 Stauffer Chemical Company N,N-dimethyl-N'-phenylthiocarbamyl formamidine and its use as an anti-inflammatory agent
US3959368A (en) 1975-04-28 1976-05-25 Stauffer Chemical Company N,N-dimethyl-N'-phenylthiocarbamyl formamidine and its use as an anti-inflammatory agent
GB1594261A (en) 1977-02-18 1981-07-30 Shell Int Research Benzyloxime ethers
US4079149A (en) 1977-06-30 1978-03-14 Shell Oil Company Benzyl oxime ethers
IL56878A (en) 1978-03-31 1984-03-30 Rhone Poulenc Inc Ketoximinoethers and their use as insecticides
US4158015A (en) 1978-08-16 1979-06-12 Mobil Oil Corporation Process for the stereoselective synthesis of the E isomer of aryl alkyl oximes
DE2907972A1 (de) 1979-03-01 1980-09-11 Bayer Ag Omega -halogen-acetophenon-oximether, verfahren zu ihrer herstellung sowie ihre verwendung als zwischenprodukte zur herstellung von omega -azolyl-acetophenon-oximethern
AU6159680A (en) 1979-08-24 1981-04-09 Rhone-Poulenc, Inc. Ketoximinoether insecticides
DE3005899A1 (de) 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Derivate des 1,2,4-triazols und imidazols, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
DE3044564A1 (de) 1980-11-26 1982-07-15 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von (alpha)-bromacetophenonoximethern
US4474815A (en) 1981-04-30 1984-10-02 Commonwealth Scientific And Industrial Research Organization Insecticidal oximes
US4566901A (en) 1982-05-06 1986-01-28 Ciba-Geigy Corporation Novel oxime ethers, the preparation thereof, compositions containing them and the use thereof
US4434182A (en) 1982-11-01 1984-02-28 Fmc Corporation Insecticidal substituted-biphenylmethyl oxime ethers
IL75858A (en) 1984-07-31 1989-02-28 Commw Scient Ind Res Org Substituted benzyl ethers of oximes,their production and their use as arthropodicides
US4824476A (en) 1985-06-24 1989-04-25 Ciba-Geigy Corporation Herbicidally active derivatives of N-phenyl-3,4,5,6-tetrahydrophthalimide
DE4213149A1 (de) * 1992-04-22 1993-10-28 Hoechst Ag Akarizide, insektizide und nematizide substituierte (Hetero)-Aryl-Alkyl-ketonoxim-O-ether, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
US5267857A (en) 1993-02-12 1993-12-07 A-Dec, Inc. Brightness control system for dental handpiece light
JP4045099B2 (ja) * 1999-11-01 2008-02-13 大正製薬株式会社 ２０−ｈｅｔｅ産生酵素阻害剤
ATE347546T1 (de) 2000-06-15 2006-12-15 Taisho Pharmaceutical Co Ltd Hydroxyformamidin-derivate und diese enthaltende medikamente
CN1272313C (zh) * 2001-04-26 2006-08-30 大正制药株式会社 20－羟基二十碳四烯酸生成抑制剂

Also Published As

Publication number Publication date
DE60125036D1 (de) 2007-01-18
WO2001096309A1 (fr) 2001-12-20
US6670382B2 (en) 2003-12-30
AU7453501A (en) 2001-12-24
KR100776095B1 (ko) 2007-11-15
DE60125036T2 (de) 2007-06-21
CN1177824C (zh) 2004-12-01
KR20030010690A (ko) 2003-02-05
AU2001274535B2 (en) 2005-06-30
EP1291343B1 (fr) 2006-12-06
CA2411418C (fr) 2010-01-12
HK1057043A1 (en) 2004-03-12
ATE347546T1 (de) 2006-12-15
EP1291343A4 (fr) 2004-04-07
CA2411418A1 (fr) 2002-12-06
EP1291343A1 (fr) 2003-03-12
US20030186979A1 (en) 2003-10-02
ES2280379T3 (es) 2007-09-16
JP4904659B2 (ja) 2012-03-28
CN1436173A (zh) 2003-08-13

Similar Documents

Publication Publication Date Title
BRPI9908319B1 (pt) composto amino cìclico, composição farmacêutica, medicamento contendo um composto amino cìclico ou um sal farmacologicamente aceitável do mesmo, e, uso de um composto amino cìclico ou um sal farmacologicamente aceitável do mesmo.
EA200900358A1 (ru) Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv
NO20085060L (no) Triazolpyrazinderivater anvendelige som anti-cancermidler
KR890012649A (ko) 아릴아미도(및 아릴티오아미도)-아자비사이클로 알칸으로 기억력을 향상시키거나 기억력 부족을 교정시키는 방법
NO884202L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazolin-2-okso-1-karboksylsyrederivater.
YU65804A (sh) Nova heterociklična jedinjenja aktivna kao inhibitori beta-laktamaze
ATE288443T1 (de) Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung
IT1228293B (it) Benzoderivati di composti eterociclici contenenti azoto.
DK1291343T3 (da) Hydroxyformamidin-derivater og lægemidler indeholdende disse
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
DE60137442D1 (de) 5-amidino-2-hydroxybenzolsulfonamidderivate, pharmazeutischen zusammensetzungen, die diese verbindungen enthalten, und zwischenprodukte zu deren herstellung
DE69910083D1 (de) Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten
DE69620175D1 (de) Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend
DK630186A (da) Pyrimido(5,4-b)(1,4)oxazinderivater, tautomer, tautomerblandinger og syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler
TH84545A (th) สารรักษาโรค
TH88198A (th) พเทอริดีนที่ใช้เป็นสารยับยั้ง hcv และวิธีสำหรับเตรียมสารเหล่านั้น
TH76318A (th) 4-ไตรฟลูออโรเมธอลซิฟีนอกซิเบนซีน-4'-ซัลโฟนิคแอซิด, กรรมวิธีสำหรับการผลิตสารเหล่านี้ และการใช้ในสารรักษาโรค
TH75469A (th) อนุพันธ์แอซิลอะมิโนไธแอโซล, ยาปรุงสำเร็จและการประยุกต์ใช้เชิงบำบัดของอนุพันธ์เหล่านั้น
TH62460A (th) ตัวยับยั้งเมทัลโลโพรทีเอสที่ได้รับการแทนที่ที่ n ซึ่งมีโซ่ข้างเฮเทอโรไซคลิค
ATE316090T1 (de) Mmp-inhibitoren
UA48054A1 (uk) Діетиламіноетиламіду-5-метил-2-(1,3,4-тіадіазоліл)-сукцинамінової кислоти гідрохлорид, який проявляє аналгетичну активність
TH51768A (th) สารประกอบคาร์บาฟีเนม การใช้ของสารดังกล่าว และสารประกอบตัวกลางสำหรับสารดังกล่าว
TH53986A (th) ซัลโฟนิลออกซาโซลามีนชนิดใหม่
TH84547A (th) สารรักษาโรค
TH64558A (fr)